The menin-KMT2A interaction promotes aberrant HOXA/MEIS1 expression across various recurrent AML genotypes and has emerged as a prominent molecular dependency that may be disrupted by a new class of selective molecules. The gene discussed is KMT2A; the disease is acute myeloid leukemia.